McDermott Will & Schulte, a global law firm

David S. Ivill works alongside health-focused private equity (PE) companies, hospitals, health systems and physician groups on their most sophisticated transactions. His experience on both sides of the health transaction deal table gives him valuable insight into the structuring best practices, and regional and sector-specific nuances that can make or break a transaction. A nationally recognized healthcare dealmaker, David has particularly deep experience with hospitals and health systems in the Northeastern United States, where he leverages his PE experience to help hospital clients maximize their transaction goals. David serves as a practice area leader for McDermott’s global Healthcare PE practice, as well as partner-in-charge of the Firm’s New York healthcare team.

David’s practice covers both the regulatory and transactional issues that come to bear in healthcare services transactions, joint ventures and other strategic collaborations. He looks beyond the traditional deal lawyer scope to prioritize the future health of the organization post-closing, incorporating considerations like physician alignment, compliance and reimbursement at the outset of negotiations. David has counseled a wide range of healthcare service providers, including Northwell Health, Crouse Hospital, Maimonides Medical Center, U.S. Renal Care and large academic medical centers, to achieve their growth and expansion goals.

He advises PE firms such as The Riverside Company, Quad-C Management, Beecken Petty O’Keefe & Company, Iron Path Capital and Deerfield Management in multi-faceted transactions. David is highly sought-after for his counsel on operational and management issues in the context of healthcare’s complex regulatory frameworks, whether it be in the course of business or in connection with affiliations, mergers and acquisitions, fraud and abuse, compliance programs, reimbursement matters or corporate practice of medicine issues.

Prior to practicing law, David was a surgeon specializing in foot and ankle reconstruction with a subspecialty in osteomyelitis of the lower extremity. He completed his residency at St. Joseph’s Hospital in Philadelphia and an AO Fellowship (for reconstructive surgery and surgical intervention for infections) in Ravensburg, Germany.

David frequently speaks on healthcare private equity matters alongside investment bankers and c-suite leaders, helping to bridge the gap between the financial and legal aspects of sophisticated healthcare transactions.